Clinical trial
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2…
NCT00398749 · Janssen-Cilag B.V., Industry · Completed
Key facts
| NCT number | NCT00398749 |
|---|---|
| Title | Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2) |
| Official title | Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 |
| Lead sponsor | Janssen-Cilag B.V., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Anemia, Neoplasms |
| Intervention type | Drug |
| Interventions | Epoetin alfa |
| Enrollment | 1,927 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Nov 14, 2006 |
| Last update posted | Nov 6, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: